Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
First Claim
1. A process of making an oligonucleoside boranophosphate, comprising (a) condensing a compound of formula (i) ##STR8## wherein:
- Ac is an acyl group or a solid support;
n is from 0 to 50;
N is a ribonucleoside or deoxyribonucleoside;
W is selected from the group consisting of ═
O, ═
S, --OPr, and --SPr where Pr is a base-labile protecting group;
X is selected from the group consisting of --OH, --BH3, --BH2 R1, --BHR1 R2 and --BR1 R2 R3 ;
R1 is selected from the group consisting of --R4, --COOOH, --COOR4, --CONHR4, --CON(R4)2, --CN+ R4, --CN, carboxycholesteryl and carboxybenzyl, wherein R4 is C1 to C18 alkyl;
R2 is selected from the group consisting of --R5, --COOH, --COOR5, --CONHR5, --CON(R5)2, --CN+ R5, --CN, carboxychoesteryl and carboxybenzyl, wherein R5 is C1 to C18 alkyl; and
R3 is selected from the group consisting of C1 to C3 alkyl,with a compound of formula (ii) ##STR9## wherein;
Pr'"'"' is a Lewis acid-labile protecting group;
N is a ribonucleoside or deoxyribonucleoside;
Y is selected from the group consisting of --OPr, and --SPr where Pr is a base-labile protecting group; and
Q is a proton acceptor which is a stronger proton acceptor than the 5'"'"' oxygen atom of compound (i);
to produce a compound of formula (iii), ##STR10## and then;
(b) oxidizing the compound of formula (iii) with a compound of the formula LX, whereinL is a Lewis base which is a weaker electron donor than the phosphite phosphorus of compound (iii); and
X is selected from the group consisting of --BH3, --BH2 R1, --BHR1 R2 and --BR1 R2 R3 ;
wherein;
R1 is selected from the group consisting of --R4, --COOH, --COOR4, --CONHR4, --CON(R4)2, --CN+ R4, --CN, carboxycholesteryl and carboxybenzyl, wherein R4 is C1 to C18 alkyl;
R2 is selected from the group consisting of --R5, --COOH, --COOR5, --CONHR5, --CON(R5)2, --CN+ R5, --CN, carboxycholesteryl and carboxybenzyl, wherein R5 is C1 to C18 alkyl; and
R3 is selected from the group consisting of C1 to C3 alkyl, to give a compound of formula (iv) ##STR11## and then (c) repeating at least step (a) by substituting the compound of formula (iv) for the compound of formula (i) in step (a).
6 Assignments
0 Petitions
Accused Products
Abstract
A process of making oligoribonucleoside and deoxyribonucleoside boranophosphates and salts thereof is disclosed. The process comprises the steps of condensing a ribonucleotide or deoxyribonucleotide with a nucleoside phosphitylating agent, wherein the phosphitylating agent includes a 5'"'"' -OH group protected by an acid-labile protecting group and a moiety bonded to the phosphorus atom therein that is a stronger proton acceptor than the 5'"'"'-OH group of the ribonucleotide or deoxyribonucleotide to form a reaction intermediate, then oxidizing the reaction intermediate so formed with a compound comprising a Lewis base and a boron-containing substituent, wherein the Lewis base is a weaker electron donor than the phosphite phosphorus of the reaction intermediate, to form a ribonucleotide or deoxyribonucleotide boranophosphate. These steps are repeated on the nucleotide boranophosphate to form an oligonucleotide boranophosphate.
-
Citations
16 Claims
-
1. A process of making an oligonucleoside boranophosphate, comprising (a) condensing a compound of formula (i) ##STR8## wherein:
- Ac is an acyl group or a solid support;
n is from 0 to 50; N is a ribonucleoside or deoxyribonucleoside; W is selected from the group consisting of ═
O, ═
S, --OPr, and --SPr where Pr is a base-labile protecting group;X is selected from the group consisting of --OH, --BH3, --BH2 R1, --BHR1 R2 and --BR1 R2 R3 ; R1 is selected from the group consisting of --R4, --COOOH, --COOR4, --CONHR4, --CON(R4)2, --CN+ R4, --CN, carboxycholesteryl and carboxybenzyl, wherein R4 is C1 to C18 alkyl; R2 is selected from the group consisting of --R5, --COOH, --COOR5, --CONHR5, --CON(R5)2, --CN+ R5, --CN, carboxychoesteryl and carboxybenzyl, wherein R5 is C1 to C18 alkyl; and R3 is selected from the group consisting of C1 to C3 alkyl, with a compound of formula (ii) ##STR9## wherein;
Pr'"'"' is a Lewis acid-labile protecting group;N is a ribonucleoside or deoxyribonucleoside; Y is selected from the group consisting of --OPr, and --SPr where Pr is a base-labile protecting group; and Q is a proton acceptor which is a stronger proton acceptor than the 5'"'"' oxygen atom of compound (i); to produce a compound of formula (iii), ##STR10## and then;
(b) oxidizing the compound of formula (iii) with a compound of the formula LX, whereinL is a Lewis base which is a weaker electron donor than the phosphite phosphorus of compound (iii); and X is selected from the group consisting of --BH3, --BH2 R1, --BHR1 R2 and --BR1 R2 R3 ;
wherein;R1 is selected from the group consisting of --R4, --COOH, --COOR4, --CONHR4, --CON(R4)2, --CN+ R4, --CN, carboxycholesteryl and carboxybenzyl, wherein R4 is C1 to C18 alkyl; R2 is selected from the group consisting of --R5, --COOH, --COOR5, --CONHR5, --CON(R5)2, --CN+ R5, --CN, carboxycholesteryl and carboxybenzyl, wherein R5 is C1 to C18 alkyl; and R3 is selected from the group consisting of C1 to C3 alkyl, to give a compound of formula (iv) ##STR11## and then (c) repeating at least step (a) by substituting the compound of formula (iv) for the compound of formula (i) in step (a). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
- Ac is an acyl group or a solid support;
Specification